Two cannabis-based medicines have been approved by the NHS in England for use to treat epilepsy and multiple sclerosis diseases.
Both medicines, which were developed in the UK, will be the first cannabis-based medicine to be legalized in the UK after clinical trials.
According to BBC, Doctors will be able to prescribe Epidyolex, for children with two types of severe epilepsy – Lennox Gastaut syndrome and Dravet syndrome – which can cause multiple seizures a day. Clinical trials have shown the oral solution, which contains cannabidiol (CBD), could reduce the number of seizures by up to 40% in some children.
The two medicines which are derived from the cannabis/marijuana plant, have been recommended for use on the NHS for the first time.
Sky News also reported that Epidyolex has been approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis (MS).